Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-02-13
1990-02-20
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 23, 546146, 546147, 546148, 546150, A61K 3147, C07D21514, C07D21536
Patent
active
049026950
ABSTRACT:
The present invention provides novel bicyclic derivatives useful as excitatory amino acid receptor antagonists and in treating a variety of associated nervous system disorders.
REFERENCES:
patent: 4746653 (1988-05-01), Hutchison et al.
patent: 4761405 (1988-08-01), Rzeszotarski et al.
Ksander et al; J. Med. Chem., vol. 28, p. 1606 (1985).
Ito, Chem. Pharm. Bull., vol. 16(3), p. 455 (1968).
Conrad Robert A.
Eli Lilly and Company
Haley Jacqueline
Lee Mary C.
Whitaker Leroy
LandOfFree
Excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1616327